Sign Up to like & get recommendations! 1
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.26337
Abstract: Key Points Question Are tumor-infiltrating lymphocytes (TILs) an independent prognostic factor for overall survival among patients with primary cutaneous melanoma? Findings This cohort study identified clinical and histopathologic characteristics of 14 436 patients with cutaneous melanoma… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2580
Abstract: The aim of this study was to investigate the tumor microenvironment immune types (TMIT) based on tumor cell programmed cell death ligand 1 (PD‐L1) expression and tumor‐infiltrating lymphocytes (TILs) distribution and whether distinct TMIT subtypes… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34013
Abstract: The significance of tumor‐infiltrating lymphocytes (TILs) in melanoma is debated. This article presents a multicenter, retrospective study assessing the predictive and prognostic value of TILs. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Cytopathology"
DOI: 10.1002/cncy.22551
Abstract: Tumor‐infiltrating lymphocytes (TILs) are associated with various clinicopathological features. Using cytologic specimens for assessing TILs remains to be established. This retrospective study aimed to establish a practical method to assess TILs in cytologic samples. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-020-02568-x
Abstract: Tumor-specific tumor-infiltrating lymphocytes (TILs) can be in vitro expanded and have the ability to induce complete and durable tumor regression in some patients with melanoma following adoptive cell therapy (ACT). In this preclinical study, we… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-020-02693-7
Abstract: Immune checkpoint inhibitors (ICIs) are emerging as the new standard of care for treating various metastatic cancers. It is known that effective anti-tumor immune responses are associated with a stronger presence of tumor-infiltrating lymphocytes (TILs)… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Radiology"
DOI: 10.1007/s00330-019-06516-x
Abstract: Objectives Tumor-infiltrating lymphocytes (TILs) have been determined as a new prognostic indicator of immunotherapy response in breast cancer (BC). The aim of this study is to investigate the effectiveness of imaging features in predicting the… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Surgery Today"
DOI: 10.1007/s00595-021-02295-5
Abstract: To clarify whether the preoperative lymphocyte/C-reactive protein (CRP) ratio (LCR) is a prognostic factor for patients with intrahepatic cholangiocarcinoma (IHCC), and investigate its mechanism via tumor-infiltrating lymphocytes. The subjects of this retrospective study were 42… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-020-05771-7
Abstract: Purpose The prognostic role of tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer (BC) is debated. We evaluated the association of TILs and clinico-pathological features with distant disease-free survival (DDFS) in patients with ER+/HER2− BC treated… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Breast"
DOI: 10.1016/j.breast.2017.07.005
Abstract: The recent success of the immune checkpoint blockade in cancer immunotherapy has modified the treatment algorithms in a variety of aggressive neoplastic diseases. Nevertheless, optimal selection of ideal candidates to these drugs remains a challenge.… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2018.02.066
Abstract: Background The immune response to melanoma is manifested locally by tumor‐infiltrating lymphocytes (TILs). Men and women are known to have varying patterns of immunity, yet sex‐specific prognostic implications of TILs have not been explored. Methods… read more here.